Logo-jnp
Original Article

1. Metformin with insulin relieves oxidative stress and confers renoprotection in type 1 diabetes in vivo
Christine Driver, Julia Achieng Hayangah, Ntsoaki Annah Nyane, Peter Mark Oroma Owira*
J Nephropathol. 2018;7(3): 171-181. doi: 10.15171/jnp.2018.37
Scopus ID: 85049646122    
Article
PDF
XML
Cited By:
8
5
Commentary

2. Renoprotective impacts of metformin with insulin in type 1 diabetes; role of its antioxidant efficacy
Esmaeel Babaeenezhad, Amin Hasanvand*
J Nephropathol. 2018;7(3): 217-219. doi: 10.15171/jnp.2018.45
Scopus ID: 85049636013    
Article
PDF
XML
Cited By:
0
0
Original Article

3. Effects of atrovastatin on concentrations of 3-hydroxy-3-methylglutaryl-coenzyme A- reductase (HMG-CoA-R), proprotein convertase subtilisin/kexin type 9 (PCSK9) and sortilin in patients with type 2 diabetes mellitus and pre-diabetics
Ali Nosrati Andevari ORCID, Soheila Moein* ORCID, Durdi Qujeq* ORCID, Zoleikha Moazezi ORCID, Karimollah Hajian Tilaki ORCID
J Nephropathol. 2021;10(1): e05. doi: 10.34172/jnp.2021.05
Scopus ID: 85089715573    
Article
PDF
XML
Cited By:
0
0
Original Article

4. Hypoglycemic agents and prognostic outcomes of chronic kidney disease patients with type 2 diabetes
Kyaw Kyaw Hoe* ORCID, Tin Lynn Han ORCID, Thant Hnin Saint Hoe ORCID
J Nephropathol. 2023;12(3): e17294. doi: 10.34172/jnp.2022.17294
Scopus ID: 85163583500    
Article
PDF
XML
Cited By:
0
0